#Coronavirus Disease Research #References (AMEDEO, Oct. 31 '26)

 

Antiviral Res

1. YAN D, Ma L, Chen J, Wu F, et al
   Nanobodies targeting the conserved post-fusion six-helix bundle core provide protective effects against SARS-CoV-2 infection and immunopathology.
   Antiviral Res. 2026 Oct 28:106562. doi: 10.1016/j.antiviral.2026.106562.
   PubMed         Abstract available
   
   
2. BARBERO-URIZ O, Gonzalez-Rubio G, Valenti M, Molina M, et al
   Novel Nirmatrelvir-Resistance Mutations in SARS-CoV-2 Mpro Using a Yeast Screening Platform.
   Antiviral Res. 2026 Oct 26:106559. doi: 10.1016/j.antiviral.2026.106559.
   PubMed         Abstract available
   
   
3. HAN Y, Zhang Q, Gao Y, Cao F, et al
   Divergent Functional Checkpoints Determine Epitope-Specific ADE Outcomes of SARS-CoV-2 Entry.
   Antiviral Res. 2026 Oct 26:106560. doi: 10.1016/j.antiviral.2026.106560.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

4. HANSON AW, Evans NJ, Pemmaraju SV, Ossai MS, et al
   Workroom contact networks: implications for COVID-19 and other respiratory infections.
   Infect Control Hosp Epidemiol. 2026 Oct 26:1-8. doi: 10.1017/ice.2026.10401.
   PubMed         Abstract available
   
   

   
   J Infect

5. MORSE RB, Egan DJS, Cheng MTK, Altaf M, et al
   Mitigation of imprinted antibody responses against COVID-19 in highly vaccinated older adults.
   J Infect. 2026 Oct 30:106883. doi: 10.1016/j.jinf.2026.106883.
   PubMed         Abstract available
   
   
6. HOFFMANN M, Zhang L, Chen N, Moor N, et al
   Epidemiology and virological characteristics of the emerging SARS-CoV-2 variant PJ.2.1.
   J Infect. 2026 Oct 24:106886. doi: 10.1016/j.jinf.2026.106886.
   PubMed        
   
   

   
   J Med Virol

7. FRICKE-GALINDO I, Ortega-Villafuerte FM, Perez-Rubio G, Buendia-Roldan I, et al
   Plasma Interleukin-10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID-19 Treated With Corticosteroids.
   J Med Virol. 2026;98:e71201.
   PubMed         Abstract available
   
   
8. BRAMANTE CT, Sturmer T, Huling JD, Buse JB, et al
   Metformin at the Time of COVID-19 Infection and Risk of Long COVID: A Target Trial Emulation Study.
   J Med Virol. 2026;98:e71190.
   PubMed         Abstract available
   
   
9. YIN J, Huang X, Ou X, Xu S, et al
   Early Risk Stratification of COVID-19 Associated Cytokine Storm Using a Four-Cytokine Cumulative Score: A Retrospective Cohort Study.
   J Med Virol. 2026;98:e71191.
   PubMed         Abstract available
   
   

   
   J Virol

10. COLARUSSO A, Stephenson KE, Collier A-RY, Wegmann F, et al
    Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy.
    J Virol. 2026 Oct 26:e0149426. doi: 10.1128/jvi.01494.
    PubMed         Abstract available
    
    

    
    Lancet

11. CATTO JWF, Thomson RM, Griffith DM, Mavhu W, et al
    A global men's health epidemiology within an intersectional framework.
    Lancet. 2026;408:1881-1898.
    PubMed         Abstract available
    
    

    
    N Engl J Med

12. PRENTICE LR, Sadler LC, Anderson KL, Wilkinson JD, et al
    In Vitro Fertilization or Intrauterine Insemination in Unexplained Infertility.
    N Engl J Med. 2026 Oct 27. doi: 10.1056/NEJMoa2602728.
    PubMed         Abstract available